Replies to post #387334 on Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

I disagree. This move means more is on his shoulders than yoking with a solid CFO to make a move off OTC. There are so many benefits to moving to NASDAQ of the future is as bright as I think it is. It will all come down to how soon does Nasrat want to sell. I’m hoping for later rather than sooner to get current pipeline launched and expand pipeline with more needlemovers vs dopamine agonist-sized products.

[NASDAQ2020]

If he is going to sell in the next few years he does not have to. UNLESS it raises the sell price significantly more.

Nasrat has NO PLANS on ever going to the Nasdaq.

[imanjen13]

As you know, NH indicated that he would reverse split the stock when the price was at a higher level in order to qualify for the listed price to qualify for Nasdaq.

At .30, a 1 for 10 reverse would move the price to $3. Shareholders holdings would be reduced to 10% of what you now own but the market value would remain the same.

I believe that is the plan unless someone buys the company for .50+ for a market cap of approximately $500M